Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05786547 · ClinicalTrials.gov registry record · Phase 3
V+PSF-M for Tobacco Cessation in HIV Care in India
A Phase 3 study of Smoking Cessation and Human Immunodeficiency Virus, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
- 2
- Study locations
NCT05786547: Recruiting Phase 3 study of Smoking Cessation and Human Immunodeficiency Virus, sponsored by University of Colorado, Denver.
NCT05786547 is a Phase 3 study of Smoking Cessation and Human Immunodeficiency Virus that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 400 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (15% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05786547, a Phase 3 study of Smoking Cessation and Human Immunodeficiency Virus, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)
Primary Outcome
Defined as abstinence from all combustible and smokeless tobacco products in the 7 days preceding 24-week follow-up supported by a negative urine cotinine test of \< 50 ng/ml
Conditions Studied
Interventions
- DRUG Varenicline
- BEHAVIORAL Standard Care
- BEHAVIORAL Positively Smoke Free Mobile (PSF-M)
Study Locations (2)
Colorado
- University of Colorado - Aurora
Tamil Nadu
- VHS Infectious Disease Medical Centre, CART Clinical Research Site - Chennai
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-01-02 |
| Est. Completion | 2026-07-22 |
| Phase | Phase 3 |
What NCT05786547 shows while recruiting
NCT05786547 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (15% lower).
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which Varenicline is the first listed.
NCT05786547 reports a single indexed study location in Colorado, Tamil Nadu.
Frequently Asked Questions
What is clinical trial NCT05786547 about?
NCT05786547 is a clinical study titled "V+PSF-M for Tobacco Cessation in HIV Care in India". The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apov...
What is the current status of trial NCT05786547?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2024-01-02. Estimated completion is 2026-07-22.
What conditions does trial NCT05786547 study?
This clinical trial studies the following conditions: Smoking Cessation, Human Immunodeficiency Virus, Smoking, Tobacco.
What interventions are being tested in trial NCT05786547?
The interventions under investigation include: Varenicline (DRUG), Standard Care (BEHAVIORAL), Positively Smoke Free Mobile (PSF-M) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05786547?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05786547 being conducted?
This trial has 2 study locations across Colorado, Tamil Nadu. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05786547's enrollment target sits among peer trials
400 68th of 188 higher than 120 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tobacco Education and Lung Health Study (TEAL)
RECRUITING · Phase 3
-
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
RECRUITING · Phase 3
-
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
COMPLETED · Phase 3
-
Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).
COMPLETED · Phase 3
-
Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
COMPLETED · Phase 3
-
Nicotine Mouth Film for Craving Relief.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI